Intravenous phenytoin: clinical and pharmacokinetic aspects

Neurology. 1978 Sep;28(9 Pt 1):874-80. doi: 10.1212/wnl.28.9.874.

Abstract

Phenytoin was administered intravenously in large doses (mean = 16.6 mg per kilogram) for prevention and treatment of seizures on 159 occasions to 139 patients aged 17 to 94 years (mean = 52 years) and weighing 37 to 113 kg (mean = 65 kg). Hypotension was more frequent among older patients. No deaths were attributable to phenytoin. Volumes of distribution were relatively constant (mean = 0.78 +/- 0.11 liters per kilogram), but half-lives varied considerably and were prolonged (mean = 51 +/- 32 hours) because of the large doses administered. A dose of 18 mg per kilogram was effective in maintaining phenytoin serum levels above 10 microgram per milliliter for 24 hours.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • Half-Life
  • Humans
  • Hypotension / chemically induced
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Phenytoin / administration & dosage*
  • Phenytoin / adverse effects
  • Phenytoin / blood

Substances

  • Phenytoin